Austin, Texas – Colossal Biosciences has announced the acquisition of Viagen (https://viagenpets.com/). According to the company announcement Colossal Biosciences is a de-extinction company that utilizes CRISPR technology for species restoration and the protection of critically…
Groundbreaking achievements include successfully grown Pigeon Primordial Germ Cells (PGCs), gene edited chicken surrogates, three new avian genomes for key dodo comparison species, the creation of a breeding colony of Nicobar pigeons in Texas, and…
According to filings with the U.S. Securities and Exchange Commission, Colossal Biosciences is raising $150,000,000.00 in new funding. Sources indicate as part of senior management Senior Executive, Brian Beard played a key role in securing…